Treatment type: Precision medicine
-
Motor neuron disease inflammation trigger discovered
In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,… Read more
-
Personalised cancer treatments a step closer
In a world-first discovery, Hudson Institute cancer researchers have discovered two potential genetic markers which could be used to provide more personalised cancer treatments to some patients.… Read more
-
Combating gene targeting challenges
Problems and potential solutions have been identified with new gene targeting medicines that could change the way they are made to help patients.… Read more
-
$2.2 million awarded to tackle rare ovarian cancer
Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods.… Read more
-
Cancer Council Victoria Postdoctoral Fellowship awarded to progress lung cancer research
Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.… Read more
-
Celebrating a successful Rebecca L Cooper Foundation Grant
Congratulations to Dr Gina Kusuma, who has been awarded a two-year Rebecca L Cooper Medical Research Foundation Project Grant to investigate cell-free therapeutics which can mediate vascular regeneration in the aged population.… Read more
-
Paving the way towards a new anti-inflammatory agent
Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.… Read more
-
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
-
Mistaken identity: new mechanism behind stomach cancer identified
Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.… Read more
-
Prestigious grant to improve newborn survival
Hudson Institute researchers have been awarded a $140,000 Vanguard Grant to improve the cardiopulmonary resuscitation (CPR) outcomes of newborn babies. … Read more